Abstract
Cytomegalovirus (CMV) is the most common cause of congenital virus infection worldwide, occurring in approximately 1% of all live borns with a prevalence ranging from 0.2% to 2.2% (Stagno et al., 1983). Congenital infection is the consequence of transplacental transfer of virus from mother to fetus. Maternal infection can either be primary or recurrent. Maternal primary infection usually results from contact with a young child in the day care environment (Demmler, 1994). Women working at day care centers, nursery schools, or preschools have an increased risk for acquisition of CMV, if seronegative (Adler, 1989). In such circumstances, the rate of acquisition can be 8%–20% as compared to 3%–5% for the general population (Pass et al., 1986, 1990; Adler, 1989; Murph et al., 1991; Alder et al., 1996). In adolescents and young adults, persistent excretion of CMV in saliva, cervical secretions, and semen incriminates sexual transmission as a mode of infection. Demographic factors, including urban residence, ethnicity, and socioeconomic status, influence the rate of acquisition of CMV. For middle and upper socioeconomic individuals, adults have seropositivity rate of 40%–60% as compared to those of lower socioeconomic status where seropositivity varies between 80%–100%. Similarly, higher rates of CMV seropositivity exist in developing countries (Griffiths and Baboonian, 1984; Ashraf et al., 1985; Wang and Evans, 1986; Yow et al., 1988; Demmler, 1994; Troendle-Atkins et al., 1994).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Adler, S.P. (1989). Cytomegalovirus and child day care. Evidence for an increased infection rate among day-care workers. N. Engl. J. Med. 321, 1290–1296.
Adler, S.P., Finney, J.W., Manganello, A.M., and Best, A.M. (1996). Prevention of child-to-mother transmission of cytomegalovirus by changing behaviors: A randomized controlled trial. Pediatr. Infect. Dis. J. 15, 240–246.
Ashraf, S.J., Parande, C.M., and Arya, S.C. (1985). Cytomegalovirus antibodies of patients in the Gizan area of Saudi Arabia. J. Infect. Dis. 152, 1351.
Boppana, S.B., Pass, R.F., Britt, W.J., Stagno, S., and Alford, C.A. (1992). Symptomatic congenital cytomegalovirus infection: Neonatal morbidity and mortality. Pediatr. Infect. Dis. J. 11, 93–99.
Demmler, G.J. (1991). Infectious Diseases Society of America and Centers for Disease Control. Summary of a workshop on surveillance for congenital cytomegalovirus disease. Rev. Infect. Dis. 13, 315–329.
Demmler, G.J. (1994). Congenital cytomegalovirus infection. Semin. Pediatr. Neurol. 1, 36–42.
Fowler, K., Stagno, S., and Pass, R. (1993). Maternal age and congenital cytomegalovirus infection: Screening of two diverse newborn populations, 1980-1990. J. Infect. Dis. 168, 552–556.
Fowler, K.B., Stagno, S., Pass, R.F., Britt, W.J., Boll, T.J., and Alford, C.A. (1992). The outcome of congenital cytomegalovirus infection in relation to maternal antibody status. N. Engl. J. Med. 326, 663–667.
Griffiths, P.D. and Baboonian, C. (1984). A prospective study of primary cytomegalovirus infection during pregnancy: Final report. Br. J. Obstet. Gynecol. 91, 307–315.
Hoffman-La Roche, I. Ganciclovir Package insert. Nutley, N. J. (1989). Cytovene(r)-IV and Cytovene(r) Capsules. IHMF Monograph. (1999). Herpesvirus infections in pregnancy. Management Strategies Workshop and 7th Annual Meeting, Seville, Spain.
Kimberlin, D.W., Lin, C.-Y, Sanchez, P.J., Demmler, G.J., Dankner, W., Shelton, M.D. et al., and the National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group. (2003). Effect of ganciclovir on hearing in symptomatic congenital cytomegalovirus disease involving the central nervous system: A randomized, controlled trial. J. Pediatr. 143, 16–25.
Marcy, S.M. and Wald, E.R. (2003). Management of acute otitis media. Pediatr. Infect. Dis. J. 22, 673–674.
Murph, J.R., Baron, J.C., Brown, K.C., Ebelhack, C.L., and Bale, J.F., Jr. (1991). The occupational risk of cytomegalovirus infection among day care providers. JAMA 265, 603–608.
Nigro, G., Scholz, H., and Bartmann, U. (1994). Ganciclovir therapy for symptomatic congenital cytomegalovirus infection in infants: A two-regimen experience. J. Pediatr. 124, 318–322.
Pass, R.F., Hutto, C., Lyon, M.D., and Cloud, G. (1990). Increased rate of cytomegalovirus infection among day care center workers. Pediatr. Infect. Dis. J. 9, 465–470.
Pass, R.F., Hutto, S.C., Ricks, R., and Cloud, G.A. (1986). Increased rate of cytomegalovirus infection among parents of children attending day care centers. N. Engl. J. Med. 314, 1414–1418.
Stagno, S. (1986). Primary cytomegalovirus infection in pregnancy: Incidence, transmission to fetus and clinical outcome in two populations of different socioeconomic backgrounds. JAMA 256, 1904–1908.
Stagno, S., Pass, R.F., Dworsky, M.E., and Alford, C.A. (1982). Maternal cytomegalovirus infection and perinatal transmission. Clin. Obstet. Gynecol. 25, 563–576.
Stagno, S., Pass, R.F., Dworsky, M.E., and Alford, C.A. (1983). Congenital and perinatal cytomegalovirus infections. Semin. Perinatal. 7, 31–42.
Trang, J.M., Kidd, L., Gruber, W., Storch, G., Demmler, G., Jacobs, R. et al., and the National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group. (1993). Linear single-dose pharmacokinetics of ganciclovir in newborns with congenital cytomegalovirus infections. Clin. Pharmacol. Ther. 53, 15–21.
Troendle-Atkins, J., Demmler, G.J., Williamson, W.D., McDonald, J.M., Istas, A.S., and Buffone, G.J. (1994). Polymerase chain reaction to detect cytomegalovirus DNA in the cerebrospinal fluid of neonates with congenital infection. J. Infect. Dis. 169, 1334–1337.
Wang, P.S. and Evans, A.S. (1986). Prevalence of antibodies to Epstein-Barr virus and cytomegalovirus in sera from a group of children in the People’s Republic of China. J. Infect. Dis. 153, 150–152.
Whitley, R.J., Cloud, G., Gruber, W., Storch, G.A., Demmler, G.J., Jacobs, R.E et al., and National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group. (1997). Ganciclovir treatment of symptomatic congenital cytomegalovirus infection: Results of a phase II Study. J. Infect. Dis. 175, 1080–1086.
Yow, M.D. and Demmler, G.J. (1992). Congenital cytomegalovirus disease: 20 years is long enough. N. Engl. J. Med. 326, 702–703.
Yow, M.D., Williamson, D.W., Leeds, L.J., Thompson, P., Woodward, R.M., Walmus, B.F. et al. (1988). Epidemiologic characteristics of cytomegalovirus infection in mothers and their infants. Am. J. Obstet. Gynecol. 58, 1189–1195.
Zhou, X.-J., Gruber, W., Demmler, G., Jacobs, R., Reuman, P., Adler, S. et al., and National Institute of Allergy and Infectious Disease Collaborative Antiviral Study Group. (1996). Population pharmacokinetics of ganciclovir in newborns with congenital cytomegalovirus infections. Antimicrob. Agents Chemother. 40, 2202–2205.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2004 Science+Business Media New York
About this paper
Cite this paper
Whitley, R.J. (2004). Congenital Cytomegalovirus Infection: Epidemiology and Treatment. In: Pollard, A.J., McCracken, G.H., Finn, A. (eds) Hot Topics in Infection and Immunity in Children. Advances in Experimental Medicine and Biology, vol 549. Springer, Boston, MA. https://doi.org/10.1007/978-1-4419-8993-2_21
Download citation
DOI: https://doi.org/10.1007/978-1-4419-8993-2_21
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-4751-4
Online ISBN: 978-1-4419-8993-2
eBook Packages: Springer Book Archive